Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE ERIC LEVY : revenue, balance sheet and financial ratios

SELARL PHARMACIE ERIC LEVY is a French company founded 4 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PARIS (75020), this company of category PME shows in 2024 a net income negative of -205 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE ERIC LEVY (SIREN 908292956)
Indicator 2024 2023 2022
Revenue N/C N/C N/C
Net income -205 163 € -123 851 € 48 420 €
EBITDA N/C N/C N/C
Net margin N/C N/C N/C

Revenue and income statement

In 2024, SELARL PHARMACIE ERIC LEVY records a net loss of 205 k€. This deficit will reduce equity on the balance sheet.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-205 163 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at -588%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -17%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

-588.473%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

-16.502%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

78.8%

Solvency indicators evolution
SELARL PHARMACIE ERIC LEVY

Sector positioning

Debt ratio
-588.47 2024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Excellent -50 pts over 3 years

In 2024, the debt ratio of SELARL PHARMACIE ERIC LEVY (-588.47) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
-16.5% 2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Watch

In 2024, the financial autonomy of SELARL PHARMACIE ERIC LEVY (-16.5%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 118.87. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

118.873

Liquidity indicators evolution
SELARL PHARMACIE ERIC LEVY

Sector positioning

Liquidity ratio
118.87 2024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Watch -35 pts over 3 years

In 2024, the liquidity ratio of SELARL PHARMACIE ERIC LEVY (118.87) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Positioning of SELARL PHARMACIE ERIC LEVY in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE ERIC LEVY with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE ERIC LEVY

What is the revenue of SELARL PHARMACIE ERIC LEVY ?

The revenue of SELARL PHARMACIE ERIC LEVY is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE ERIC LEVY profitable?

SELARL PHARMACIE ERIC LEVY recorded a net loss in 2024.

Where is the headquarters of SELARL PHARMACIE ERIC LEVY ?

The headquarters of SELARL PHARMACIE ERIC LEVY is located in PARIS (75020), in the department Paris.

Where to find the tax return of SELARL PHARMACIE ERIC LEVY ?

The tax return of SELARL PHARMACIE ERIC LEVY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE ERIC LEVY operate?

SELARL PHARMACIE ERIC LEVY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.